|4Mar 7, 4:43 PM ET

INOVIO PHARMACEUTICALS, INC. 4

4 · INOVIO PHARMACEUTICALS, INC. · Filed Mar 7, 2017

Insider Transaction Report

Form 4
Period: 2017-03-05
Bagarazzi Mark
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2017-03-05+8,33328,825 total
  • Exercise/Conversion

    Restricted Stock Unit

    2017-03-058,3338,333 total
    Common Stock (8,333 underlying)
  • Tax Payment

    Common Stock

    2017-03-06$6.95/sh3,067$21,31625,758 total
Footnotes (1)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 25,000 restricted stock units is as follows: 8,334 shares vested on March 5, 2016; 8,333 shares vested on March 5, 2017; 8,333 shares will vest on March 5, 2018. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both.

Documents

1 file
  • 4
    wf-form4_148892296898694.xmlPrimary

    FORM 4